BBVA USA’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$475K Sell
8,456
-108
-1% -$5.93K 0.03% 339
2021
Q2
$446K Buy
+8,564
New +$411K 0.02% 361

Other funds holding PBH

BBVA USA's PBH Position: Q3 2021 in Review

BBVA USA reduced its Prestige Consumer Healthcare (PBH) stake by 1.3% in Q3 2021, selling an estimated $5.93K and leaving 8,456 shares worth $475K. The position accounts for 0.03% of the portfolio, ranked #339.

BBVA USA first reported a position in PBH in Q2 2021 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold PBH as of Q3 2021.

  • BBVA USA held 8,456 shares of Prestige Consumer Healthcare worth $475K as of Q3 2021.
  • BBVA USA sold 108 Prestige Consumer Healthcare shares in Q3 2021, an estimated $5.93K.
  • Prestige Consumer Healthcare made up 0.03% of BBVA USA's portfolio in Q3 2021, its #339 holding.
  • BBVA USA first reported a position in Prestige Consumer Healthcare in Q2 2021 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.